about
Identification and characterization of a novel DGAT1 missense mutation associated with congenital diarrheaCardiac Ion Channel Regulation in Obesity and the Metabolic Syndrome: Relevance to Long QT Syndrome and Atrial FibrillationDiabetic Cardiomyopathy: An Immunometabolic Perspective.Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.Targeting β3-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade.Metabolism in cardiomyopathy: every substrate matters.Obesity and heart failure: when 'epidemics' collide.Cardiac overexpression of perilipin 2 induces dynamic steatosis: prevention by hormone-sensitive lipase.Amylin and diabetic cardiomyopathy - amylin-induced sarcolemmal Ca2+ leak is independent of diabetic remodeling of myocardium.Markers of maternal and infant metabolism are associated with ventricular dysfunction in infants of obese women with type 2 diabetes.Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity.Bariatric surgery as a treatment for heart failure: review of the literature and potential mechanisms.Adipose tissue ATGL modifies the cardiac lipidome in pressure-overload-induced left ventricular failure.The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity.What You Eat Affects Your Shape.Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts.The Expression of Uncoupling Protein 3 Coincides With the Fatty Acid Oxidation Type of Metabolism in Adult Murine Heart.
P2860
Q33754253-1D3A52F5-4D3F-4E0D-BEAE-BF09CB1E647AQ33820434-501D06D4-4DC9-4472-A72D-9CF7BF115A07Q37741735-DAF8FD0E-5365-4B0B-B436-7445B2C58A87Q38937414-5D2AD9C4-BDBB-4A16-9747-8DC194737291Q38974127-2B2699E1-D258-42C8-A548-28E33B500E64Q39232032-3347B9B6-8377-42B1-9DEF-9349CBAE80BCQ42038790-DFE2B748-3117-4E85-8996-B8F2B3C2FA22Q46011740-4842B824-034A-4A5C-B66B-09DDB4F0FFA2Q46028408-4383ECFB-ECFF-403E-A7AC-FCCF0AF82F6FQ47128298-630B86E5-479B-4C96-966F-0926C75E1D72Q47649685-F15DD9AB-5124-465C-85B4-ACCE1E47FF08Q47665434-10142CB7-3F0A-499A-AEAD-CFDCE3E28BA9Q48270121-88AD2D06-0F9C-4A8E-80B4-1711B91F831DQ48580620-7725106E-14D5-4496-ADF4-5F80C7607DE6Q50187397-A4ADA621-9AA8-443C-8A95-E842919A7B55Q52575994-107E08B5-1724-422B-A861-3A00EC963210Q55384960-23E7AAA0-E523-4BD8-BA1C-58CA00B1CDA5Q55514873-1F23C29C-78BE-4998-8AAD-E0CB3466B84D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipid Use and Misuse by the Heart.
@en
Lipid Use and Misuse by the Heart.
@nl
type
label
Lipid Use and Misuse by the Heart.
@en
Lipid Use and Misuse by the Heart.
@nl
prefLabel
Lipid Use and Misuse by the Heart.
@en
Lipid Use and Misuse by the Heart.
@nl
P2860
P1433
P1476
Lipid Use and Misuse by the Heart
@en
P2093
Ira J Goldberg
P Christian Schulze
P2860
P304
P356
10.1161/CIRCRESAHA.116.306842
P577
2016-05-01T00:00:00Z